These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38433860)

  • 1. When leuprolide acetate is essential to care: A review of the literature and framework for assessing drug allergy.
    Belmont AP; Rosano J; Criscione J; Stone CA; Leeds S
    J Allergy Clin Immunol Glob; 2024 May; 3(2):100210. PubMed ID: 38433860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent anaphylaxis associated with gonadotropin-releasing hormone analogs: case report and review of the literature.
    Lam C; Tjon J; Hamilton J; Ahmet AH
    Pharmacotherapy; 2006 Dec; 26(12):1811-5. PubMed ID: 17125443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-threatening anaphylaxis to leuprorelin acetate depot: case report and review of the literature.
    Fujisaki A; Kondo Y; Goto K; Morita T
    Int J Urol; 2012 Jan; 19(1):81-4. PubMed ID: 22050405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depot) in children with precocious puberty.
    Kappy M; Stuart T; Perelman A; Clemons R
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1087-9. PubMed ID: 2507570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study on the effectiveness and safety of combined laparoscopy and gonadotropin-releasing hormone agonist in the treatment of endometriosis].
    Song JH; Lu H; Zhang J; Li B
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):584-8. PubMed ID: 24199923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depot-leuprolide acetate for treatment of paraphilias: a report of twelve cases.
    Krueger RB; Kaplan MS
    Arch Sex Behav; 2001 Aug; 30(4):409-22. PubMed ID: 11446201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Systemic Hypersensitivity Reactions to Gonadotropin-Releasing Hormone Analogues during Treatment of Central Precocious Puberty.
    Kirkgoz T; Karakoc-Aydiner E; Bugrul F; Yavas Abali Z; Helvacioglu D; Kiykim A; Bilgic Eltan S; Aruci Kasap N; Baris S; Ozen A; Guran T; Bereket A; Turan S
    Horm Res Paediatr; 2020; 93(1):66-72. PubMed ID: 31972562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relugolix, an oral gonadotropin-releasing hormone antagonist for the treatment of prostate cancer.
    George DJ; Dearnaley DP
    Future Oncol; 2021 Nov; 17(33):4431-4446. PubMed ID: 34409852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous low dose leuprolide acetate depot versus leuprolide acetate for women undergoing ovarian stimulation for in-vitro fertilization.
    Tsai HD; Chen CM; Lo HY; Chang CC
    Hum Reprod; 1995 Nov; 10(11):2909-12. PubMed ID: 8747042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancer.
    Tomera K; Gleason D; Gittelman M; Moseley W; Zinner N; Murdoch M; Menon M; Campion M; Garnick MB
    J Urol; 2001 May; 165(5):1585-9. PubMed ID: 11342922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer.
    Koh Y; Kawashima A; Ujike T; Nagahara A; Fujita K; Kiuchi H; Imamura R; Miyagawa Y; Nonomura N; Uemura M
    Anticancer Drugs; 2020 Nov; 31(10):1099-1102. PubMed ID: 32804697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Hypersensitivity Reactions with Leuprolide Acetate and Triptorelin Acetate in Children.
    Metbulut AP; Adıgüzel KT; İslamoğlu C; Boyraz M; Mısırlıoğlu ED
    Indian J Endocrinol Metab; 2021; 25(6):527-531. PubMed ID: 35355908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls.
    Brito VN; Latronico AC; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4338-42. PubMed ID: 15356030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 36-month treatment experience of two doses of leuprolide acetate 3-month depot for children with central precocious puberty.
    Lee PA; Klein K; Mauras N; Lev-Vaisler T; Bacher P
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3153-9. PubMed ID: 24926950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty.
    Klein KO; Freire A; Gryngarten MG; Kletter GB; Benson M; Miller BS; Dajani TS; Eugster EA; Mauras N
    J Clin Endocrinol Metab; 2020 Oct; 105(10):e3660-71. PubMed ID: 32738042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leuprorelin acetate granulomas: case reports and review of the literature.
    Yasukawa K; Sawamura D; Sugawara H; Kato N
    Br J Dermatol; 2005 May; 152(5):1045-7. PubMed ID: 15888168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A semi-mechanistic integrated pharmacokinetic/pharmacodynamic model of the testosterone effects of the gonadotropin-releasing hormone agonist leuprolide in prostate cancer patients.
    Lim CN; Salem AH
    Clin Pharmacokinet; 2015 Sep; 54(9):963-73. PubMed ID: 25791895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group.
    Hornstein MD; Surrey ES; Weisberg GW; Casino LA
    Obstet Gynecol; 1998 Jan; 91(1):16-24. PubMed ID: 9464714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depot leuprolide acetate dosage for sexual precocity.
    Parker KL; Baens-Bailon RG; Lee PA
    J Clin Endocrinol Metab; 1991 Jul; 73(1):50-2. PubMed ID: 1904452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.